Position in LLY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$185,363,525
+$53,555,886 QoQ
Shares Held
154,543
+7.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
2.11%
of 13F equity value
Holder Rank
#272
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sequoia Financial Advisors, LLC holds $404,940,719 across 16 Drug Manufacturers - General names. LLY ranks #1 (45.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
154,543 | $185,363,525 | |
| 2 | AMGN |
Amgen Inc
|
173,024 | $62,655,450 | |
| 3 | JNJ |
Johnson & Johnson
|
203,267 | $51,623,719 | |
| 4 | MRK |
Merck & Co., Inc.
|
292,117 | $37,537,034 | |
| 5 | ABBV |
AbbVie Inc.
|
94,884 | $23,876,609 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
179,874 | $10,364,339 | |
| 7 | PFE |
Pfizer Inc
|
332,178 | $7,998,846 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
58,662 | $7,411,357 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $185,363,525 | 154,543 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $131,807,639 | 143,305 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $158,719,503 | 147,690 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $111,567,386 | 146,222 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $109,290,885 | 140,201 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $97,284,764 | 117,791 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $78,539,420 | 101,735 | Shares | Sole | 2025-08-08 | |
| 2024-09-30 | $60,678,030 | 68,490 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $56,514,724 | 62,421 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $42,620,538 | 54,785 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $37,495,163 | 64,323 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $7,490,277 | 13,945 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,669,364 | 14,221 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,644,412 | 13,524 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $4,765,431 | 13,026 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,924,902 | 5,953 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $2,140,242 | 6,601 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $2,417,821 | 8,443 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,909,232 | 6,912 | Shares | Sole | 2022-02-22 | |
| 2021-09-30 | $571,155 | 2,472 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,362,430 | 5,936 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $1,025,268 | 5,488 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $917,138 | 5,432 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $719,229 | 4,859 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $784,287 | 4,777 | Shares | Sole | 2020-08-25 | |
| 2020-03-31 | $725,783 | 5,232 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||